Custom service

Site-Specific Peptide Conjugation

Install conjugation handles at defined residues instead of random lysine labeling

Turnaround: 5–8 weeksTypical scale: 0.1–50 mg conjugate per batchChemistry options: unnatural amino-acid handles (azido acids); Cys-selective maleimide with hydrolysis control; enzymatic ligation (sortase, transglutaminase)

The service is built around unnatural amino-acid handles (azido acids). Depending on the molecule we may move to Cys-selective maleimide with hydrolysis control or enzymatic ligation (sortase, transglutaminase) to improve stability, loading or yield, and every batch is released with site-specific conjugate with attachment-site mapping.

Because Site-Specific Peptide Conjugation projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.

Homogeneous constructs where random labeling destroys potency

Process development ahead of controlled manufacturing

Fast, low-cost research labeling where heterogeneity is acceptable

Conjugates whose payload cannot tolerate aqueous coupling conditions

Every conjugation batch is documented from vial to vial: carrier lot, payload lot, reagent lots, reaction conditions and purification chromatograms. The release package contains the loading ratio measured by an orthogonal method (UV, ICP-MS or amino-acid analysis), identity by mass spectrometry where the conjugate permits it, and residual-free-payload data.

Service Highlights

  • Unnatural amino-acid handles (azido acids) as the default route, with Cys-selective maleimide with hydrolysis control held as a proven fallback
  • Enzymatic ligation (sortase, transglutaminase) worked into the design where the application requires it
  • Carrier and payload compatibility screened in a small feasibility batch before full material is committed
  • Analytical confirmation of every intermediate before the final release
  • Unreacted payload driven below the detection limit of the release assay before purification is closed
  • Site-specific conjugate with attachment-site mapping delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Scope & design

    We review the payload, the carrier and the intended assay or study, and propose between unnatural amino-acid handles (azido acids) and Cys-selective maleimide with hydrolysis control as candidate routes.

  2. Feasibility screen

    A milligram-scale screen compares loading, residual payload and activity across the candidate conditions.

  3. Production conjugation

    The selected condition is executed at project scale with in-process sampling at fixed time points.

  4. Purification

    Size-exclusion, dialysis or magnetic separation removes free payload and by-products.

  5. Characterization & release

    Identity, loading ratio and functional activity are measured against the agreed specification.

  6. Documentation & hand-off

    Site-specific conjugate with attachment-site mapping is packaged with the full batch record, released for shipment after QC sign-off.

Specifications & timeline

Turnaround
5–8 weeks
Typical scale
0.1–50 mg conjugate per batch
Chemistry options
unnatural amino-acid handles (azido acids); Cys-selective maleimide with hydrolysis control; enzymatic ligation (sortase, transglutaminase)
Deliverable
Site-specific conjugate with attachment-site mapping
QC package
HPLC/SEC trace, MALDI-TOF or ESI-MS, UV/Vis or ICP-MS loading ratio
Shipping
Blue ice or dry ice as the payload requires, with a cold-chain manifest

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.